Corrigendum

This article refers to:

Asthma causes inflammation of human pulmonary arteries and decreases vasodilatation induced by prostaglandin I2 analogs

Article title: “Asthma causes inflammation of human pulmonary arteries and decreases vasodilatation induced by prostaglandin I2 analogs”

Authors: Nabil Foudi, Aouatef Badi, Mounira Amrane, and Wassim Hodroj

Journal: Journal of Asthma

DOI: 10.1080/02770903.2017.1292282^{Table 2}

Table 2. E_max and pEC50 values of vasoconstriction induced by selective agonists in human pulmonary arteries from non-asthmatic (Control, n = 8) and asthmatic (Asthma, n = 6) patients. Values are means±s.e.mean derived from (n) different patients. E_max indicates maximal vasoconstriction effect. (NC) indicates not calculable. Ring were treated for 30 min with L-N^G-nitroarginine methyl ester (1 mmol/L) and salicylic acid (100 µmol/L) before vasoconstriction protocols.

	Control		Asthma
Agonists	pEC50	Emax (grams)	pEC50	Emax (grams)
Norepinephrine	7.01 ± 0.20	1.67 ± 0.24	6.99 ± 0.39	1.72 ± 0.28
Angiotensin II	8.03 ± 0.29	1.46 ± 0.19	8.07 ± 0.16	1.56 ± 0.22
KCl	NC	3.02 ± 0.22	NC	2.99 ± 0.35
Prostaglandin E2	6.31 ± 0.22	1.25 ± 0.55	6.19 ± 0.25	1.33 ± 0.34
U46619	7.20 ± 0.18	3.88 ± 1.07	7.48 ± 0.28	3.76 ± 1.18